363 related articles for article (PubMed ID: 18211895)
1. MEL-18 interacts with HSF2 and the SUMO E2 UBC9 to inhibit HSF2 sumoylation.
Zhang J; Goodson ML; Hong Y; Sarge KD
J Biol Chem; 2008 Mar; 283(12):7464-9. PubMed ID: 18211895
[TBL] [Abstract][Full Text] [Related]
2. Mel-18 interacts with RanGAP1 and inhibits its sumoylation.
Zhang J; Sarge KD
Biochem Biophys Res Commun; 2008 Oct; 375(2):252-5. PubMed ID: 18706886
[TBL] [Abstract][Full Text] [Related]
3. Small ubiquitin-like modifier (SUMO) modification of zinc finger protein 131 potentiates its negative effect on estrogen signaling.
Oh Y; Chung KC
J Biol Chem; 2012 May; 287(21):17517-17529. PubMed ID: 22467880
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of DNA binding by differential sumoylation of heat shock factors.
Anckar J; Hietakangas V; Denessiouk K; Thiele DJ; Johnson MS; Sistonen L
Mol Cell Biol; 2006 Feb; 26(3):955-64. PubMed ID: 16428449
[TBL] [Abstract][Full Text] [Related]
5. Modification of de novo DNA methyltransferase 3a (Dnmt3a) by SUMO-1 modulates its interaction with histone deacetylases (HDACs) and its capacity to repress transcription.
Ling Y; Sankpal UT; Robertson AK; McNally JG; Karpova T; Robertson KD
Nucleic Acids Res; 2004; 32(2):598-610. PubMed ID: 14752048
[TBL] [Abstract][Full Text] [Related]
6. Identification of a non-covalent ternary complex formed by PIAS1, SUMO1, and UBC9 proteins involved in transcriptional regulation.
Mascle XH; Lussier-Price M; Cappadocia L; Estephan P; Raiola L; Omichinski JG; Aubry M
J Biol Chem; 2013 Dec; 288(51):36312-27. PubMed ID: 24174529
[TBL] [Abstract][Full Text] [Related]
7. Dynamin interacts with members of the sumoylation machinery.
Mishra RK; Jatiani SS; Kumar A; Simhadri VR; Hosur RV; Mittal R
J Biol Chem; 2004 Jul; 279(30):31445-54. PubMed ID: 15123615
[TBL] [Abstract][Full Text] [Related]
8. E2-mediated small ubiquitin-like modifier (SUMO) modification of thymine DNA glycosylase is efficient but not selective for the enzyme-product complex.
Coey CT; Fitzgerald ME; Maiti A; Reiter KH; Guzzo CM; Matunis MJ; Drohat AC
J Biol Chem; 2014 May; 289(22):15810-9. PubMed ID: 24753249
[TBL] [Abstract][Full Text] [Related]
9. The polycomb protein Pc2 is a SUMO E3.
Kagey MH; Melhuish TA; Wotton D
Cell; 2003 Apr; 113(1):127-37. PubMed ID: 12679040
[TBL] [Abstract][Full Text] [Related]
10. RWD Domain as an E2 (Ubc9)-Interaction Module.
Alontaga AY; Ambaye ND; Li YJ; Vega R; Chen CH; Bzymek KP; Williams JC; Hu W; Chen Y
J Biol Chem; 2015 Jul; 290(27):16550-9. PubMed ID: 25918163
[TBL] [Abstract][Full Text] [Related]
11. Small ubiquitin-like modifier (SUMO) conjugation impedes transcriptional silencing by the polycomb group repressor Sex Comb on Midleg.
Smith M; Mallin DR; Simon JA; Courey AJ
J Biol Chem; 2011 Apr; 286(13):11391-400. PubMed ID: 21278366
[TBL] [Abstract][Full Text] [Related]
12. Sumoylation of human argonaute 2 at lysine-402 regulates its stability.
Sahin U; Lapaquette P; Andrieux A; Faure G; Dejean A
PLoS One; 2014; 9(7):e102957. PubMed ID: 25036361
[TBL] [Abstract][Full Text] [Related]
13. In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity.
Yang WS; Campbell M; Kung HJ; Chang PC
J Vis Exp; 2018 Jan; (131):. PubMed ID: 29443041
[TBL] [Abstract][Full Text] [Related]
14. Small ubiquitin-like modifier (SUMO) modification of E1 Cys domain inhibits E1 Cys domain enzymatic activity.
Truong K; Lee TD; Chen Y
J Biol Chem; 2012 May; 287(19):15154-63. PubMed ID: 22403398
[TBL] [Abstract][Full Text] [Related]
15. SIM-dependent enhancement of substrate-specific SUMOylation by a ubiquitin ligase in vitro.
Parker JL; Ulrich HD
Biochem J; 2014 Feb; 457(3):435-40. PubMed ID: 24224485
[TBL] [Abstract][Full Text] [Related]
16. Rhes, a physiologic regulator of sumoylation, enhances cross-sumoylation between the basic sumoylation enzymes E1 and Ubc9.
Subramaniam S; Mealer RG; Sixt KM; Barrow RK; Usiello A; Snyder SH
J Biol Chem; 2010 Jul; 285(27):20428-32. PubMed ID: 20424159
[TBL] [Abstract][Full Text] [Related]
17. Ubc9 acetylation modulates distinct SUMO target modification and hypoxia response.
Hsieh YL; Kuo HY; Chang CC; Naik MT; Liao PH; Ho CC; Huang TC; Jeng JC; Hsu PH; Tsai MD; Huang TH; Shih HM
EMBO J; 2013 Mar; 32(6):791-804. PubMed ID: 23395904
[TBL] [Abstract][Full Text] [Related]
18. Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation.
Wiechmann S; Gärtner A; Kniss A; Stengl A; Behrends C; Rogov VV; Rodriguez MS; Dötsch V; Müller S; Ernst A
J Biol Chem; 2017 Sep; 292(37):15340-15351. PubMed ID: 28784659
[TBL] [Abstract][Full Text] [Related]
19. Structural insights into the regulation of the human E2∼SUMO conjugate through analysis of its stable mimetic.
Goffinont S; Coste F; Prieu-Serandon P; Mance L; Gaudon V; Garnier N; Castaing B; Suskiewicz MJ
J Biol Chem; 2023 Jul; 299(7):104870. PubMed ID: 37247759
[TBL] [Abstract][Full Text] [Related]
20. A role for non-covalent SUMO interaction motifs in Pc2/CBX4 E3 activity.
Merrill JC; Melhuish TA; Kagey MH; Yang SH; Sharrocks AD; Wotton D
PLoS One; 2010 Jan; 5(1):e8794. PubMed ID: 20098713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
